USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/1434
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGroppa, Liliana
dc.contributor.authorRussu, Eugen
dc.contributor.authorChişlari, Lia
dc.contributor.authorRotari, Larisa
dc.contributor.authorAgachi, Svetlana
dc.date.accessioned2019-06-10T14:51:59Z
dc.date.available2019-06-10T14:51:59Z
dc.date.issued2017
dc.identifier.citationGROPPA, Liliana; RUSSU, Eugen; CHIŞLARI, Lia; ROTARI, Larisa; AGACHI, Svetlana. Importanţa manifestărilor procesului inflamator în diagnosticul timpurii la pacienţii cu spondiloartrită anchilozantă. In: Sănătate Publică, Economie şi Management în Medicină. 2017, nr. 3(73), pp. 135-139. ISSN 1729-8687.en_US
dc.identifier.issn1729-8687
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/1434
dc.identifier.urihttp://revistaspemm.md/wp-content/uploads/2019/04/cm3_73_2017cg-2.pdf
dc.descriptionDepartamentul Medicină Internă, IP USMF Nicolae Testemiţanuen_US
dc.description.abstractThe disease activity threshold necessary to start DMARD by combined or monotherapy was established arbitrary, for patient with axial spondyloarthritis, at BASDAI ≥ 4. At the moment, the correlation between the activity of the disease and pain, inflammation and the impairment of spinal motor function. The objection of the study was to systematically compare the clinical, laboratory and radiological data of patients with SpAax with the BASDAI index. 100 patients that haven’t been previously treated with biological drugs were included in the study.en_US
dc.language.isoroen_US
dc.publisherAsociația Obștească "Economie, Management și Psihologie în Medicină" din Republica Moldovaen_US
dc.relation.ispartofSănătate Publică, Economie şi Management în Medicină: Al III-lea Congres al medicilor interniști din Republica Moldova cu participare internațională 24–25 octombrie 2017 Chișinău, Republica Moldova
dc.subject.ddcCZU 616.721-002.77-07
dc.subject.meshSpondylitis, Ankylosing--diagnosisen_US
dc.subject.meshSpondylitis, Ankylosing--complicationsen_US
dc.subject.meshInflammation--diagnosisen_US
dc.subject.meshMotor Activity--physiologyen_US
dc.subject.meshMusculoskeletal System--physiopathologyen_US
dc.subject.meshAntirheumatic Agents--therapeutic useen_US
dc.titleImportanţa manifestărilor procesului inflamator în diagnosticul timpuriu la pacienţii cu spondiloartrită anchilozantăen_US
dc.title.alternativeImportance of inflammatory process manifestations in early diagnosis in patients with ankylosing spondylitisen_US
dc.typeOtheren_US
Appears in Collections:Sănătate Publică, Economie şi Management în Medicină Nr. 3 (73) / 2017

Files in This Item:
File Description SizeFormat 
IMPORTANTA_MANIFESTARILOR_PROCESULUI.pdf302.8 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback